Troriluzole HCl salt form · salt · Parent Troriluzole

Troriluzole hydrochloride is a third-generation peptide precursor of Riluzole and is an orally active glutamate modulator.

For research use only. Not for human or veterinary use.

Target mGluR

Research area Neurological Disease

Purity >98% Stock Inquire

Data Sheet SDS COA

Troriluzole HCl structure

CAS No.: 1926204-76-3

Download structure (.mol)

Pack sizes & pricing

Size	Price	SKU	Stock
25 mg	USD 460.00	BP-02418A-25mg	In stock	Get quote
50 mg	USD 740.00	BP-02418A-50mg	In stock	Get quote
100 mg	USD 1,180.00	BP-02418A-100mg	In stock	Get quote
250 mg	USD 2,360.00	BP-02418A-250mg	In stock	Get quote
500 mg	USD 3,770.00	BP-02418A-500mg	In stock	Get quote
1 g	Inquire	BP-02418A-1g	In stock	Inquire

Need another size or custom synthesis? Request a quote.

Related forms

BP-02418 — Troriluzole

Description

Troriluzole hydrochloride is a third-generation peptide precursor of Riluzole and is an orally active glutamate modulator. Troriluzole hydrochloride can reduce synaptic glutamate levels and enhance the uptake of synaptic glutamate. Troriluzole hydrochloride shows potential for treating Alzheimer's disease and Generalized Anxiety Disorder (GAD) .

Identifiers

SMILES: O=C(CN(C)C(CNC(CN)=O)=O)NC1=NC2=CC=C(OC(F)(F)F)C=C2S1.Cl
InChIKey: ZRZLEMQBDKNTLJ-UHFFFAOYSA-N

Specifications

MW (average): 455.8400
Formula: C₁₅H₁₇ClF₃N₅O₄S
CAS No.: 1926204-76-3
Physical state: Solid
Color: White to off-white
Shipping: —
Storage: —

Documents

References

[1].Schanzer B, et al. Novel investigational therapeutics for generalized anxiety disorder (GAD). Expert Opin Investig Drugs. 2019 Nov;28(11):1003-1012.

[2].Huang LK, et al. Clinical trials of new drugs for Alzheimer disease. J Biomed Sci. 2020 Jan 6;27(1):18.

Same research area

Search Neurological Disease